Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Emily Sterbis

Concepts (69)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Embolization, Therapeutic
2
2026
246
0.820
Why?
Vena Cava Filters
1
2023
68
0.710
Why?
Osteoarthritis, Knee
1
2022
291
0.580
Why?
Knee Joint
1
2022
453
0.550
Why?
Carcinoma, Non-Small-Cell Lung
1
2022
1195
0.380
Why?
Lung Neoplasms
1
2022
2675
0.280
Why?
Neoplasms
1
2023
2954
0.250
Why?
Arteriovenous Malformations
1
2026
34
0.230
Why?
Pulmonary Veins
1
2026
110
0.220
Why?
Watchful Waiting
1
2023
90
0.180
Why?
Device Removal
1
2023
149
0.170
Why?
Radiopharmaceuticals
1
2022
210
0.170
Why?
Fluorodeoxyglucose F18
1
2022
164
0.170
Why?
Positron Emission Tomography Computed Tomography
1
2022
122
0.170
Why?
Arteries
1
2022
261
0.160
Why?
Arthritis, Infectious
2
2018
77
0.160
Why?
Positron-Emission Tomography
1
2022
343
0.160
Why?
Pulmonary Artery
1
2026
1116
0.160
Why?
Pain Management
1
2022
421
0.140
Why?
Retrospective Studies
5
2026
17438
0.140
Why?
Blood Loss, Surgical
1
2018
117
0.130
Why?
Prosthesis-Related Infections
1
2018
100
0.130
Why?
Pain
1
2022
790
0.130
Why?
Warfarin
1
2018
179
0.120
Why?
Medicare
1
2022
920
0.120
Why?
Arthroplasty, Replacement, Knee
2
2018
385
0.110
Why?
Arthroplasty, Replacement, Hip
1
2018
193
0.110
Why?
Osteoarthritis
1
2018
206
0.110
Why?
Reoperation
1
2018
645
0.110
Why?
Preoperative Care
1
2018
396
0.110
Why?
Prediabetic State
1
2018
250
0.110
Why?
Aspirin
1
2018
405
0.100
Why?
Platelet Aggregation Inhibitors
1
2018
499
0.100
Why?
Venous Thromboembolism
1
2018
332
0.100
Why?
Anticoagulants
1
2018
746
0.090
Why?
Cohort Studies
1
2023
6077
0.090
Why?
Aged
5
2026
26432
0.080
Why?
Mass Screening
1
2018
1307
0.070
Why?
Middle Aged
5
2026
36619
0.070
Why?
Humans
7
2026
146342
0.070
Why?
Retreatment
1
2026
79
0.060
Why?
Postoperative Complications
1
2018
3034
0.050
Why?
United States
1
2022
16136
0.050
Why?
Male
5
2026
73396
0.050
Why?
Female
5
2026
79499
0.050
Why?
Aged, 80 and over
3
2018
8391
0.040
Why?
Incidence
2
2018
2936
0.040
Why?
Young Adult
3
2026
14330
0.040
Why?
International Normalized Ratio
1
2018
55
0.030
Why?
Philadelphia
1
2018
55
0.030
Why?
Tranexamic Acid
1
2018
63
0.030
Why?
Adult
4
2026
41087
0.030
Why?
Diabetes Complications
1
2018
219
0.030
Why?
Elective Surgical Procedures
1
2018
216
0.030
Why?
Drug Administration Schedule
1
2018
790
0.030
Why?
Venous Thrombosis
1
2018
199
0.030
Why?
Pulmonary Embolism
1
2018
246
0.030
Why?
Blood Transfusion
1
2018
394
0.030
Why?
Risk Factors
2
2018
10921
0.020
Why?
Dose-Response Relationship, Drug
1
2018
2022
0.020
Why?
Logistic Models
1
2018
2126
0.020
Why?
Treatment Outcome
1
2026
11821
0.020
Why?
Prevalence
1
2018
2861
0.020
Why?
Diabetes Mellitus
1
2018
1101
0.020
Why?
Blood Glucose
1
2018
2360
0.020
Why?
Adolescent
1
2026
22557
0.020
Why?
Child
1
2026
22693
0.010
Why?
Prospective Studies
1
2018
8123
0.010
Why?
Diabetes Mellitus, Type 2
1
2018
2623
0.010
Why?
Sterbis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)